Skip to main content

Month: April 2021

Matthews International Announces Second Quarter Fiscal 2021 Earnings Release and Conference Call

PITTSBURGH, April 09, 2021 (GLOBE NEWSWIRE) — Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its second quarter fiscal year 2021 earnings results after the market closes on Thursday, April 29, 2021. The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its outlook. Participating in the call will be Joseph C. Bartolacci, President and CEO, and Steven F. Nicola, Chief Financial Officer. A question-and-answer session will follow. Second Quarter Fiscal Year 2021 Conference CallFriday, April 30, 20219:00 a.m. Eastern TimePhone: 201-689-8471Webcast and accompanying slide presentation: www.matw.com A telephonic replay will be available from 12:00 p.m. ET on the day of the teleconference call until Friday, May 14, 2021. To listen...

Continue reading

Notice to Annual General Meeting 2021

Shareholders inMICRO SYSTEMATION AB (publ) are hereby given notice to attend the Annual General Meeting (AGM) on Tuesday, 11 May 2021, at 18.00 at MSAB’s premises at Hornsbruksgatan 28 in Stockholm. Registration for the AGM will commence at 17:15. Because of COVID-19 (the Corona virus), MSAB is prioritising health and safety and has thus decided to hold the AGM on Company premises, Hornsbruksgatan 28 in Stockholm, and keep the meeting as brief as possible and to provide the opportunity for shareholders to also vote by post. No food will be served. The demonstration and display of the Company’s products normally given in conjunction with the AGM are cancelled. Questions for Company management can be sent to info@msab.com. Against the backdrop of recommendations issued by Swedish authorities, all shareholders are encouraged to consider...

Continue reading

Kallelse till årsstämma 2021

Aktieägare iMICRO SYSTEMATION AB (publ) kallas härmed till årsstämma tisdagen den 11 maj 2021 kl. 18.00 i MSABs lokaler på Hornsbruksgatan 28 i Stockholm. Inregistrering till årsstämman börjar klockan 17:15. Med anledning av COVID-19 (Corona-viruset) har MSAB, för att sätta hälsa och säkerhet i första rummet, beslutat att hålla stämman i bolagets lokaler, Hornsbruksgatan 28 i Stockholm och att korta stämman så långt som möjligt, samt ge aktieägarna möjlighet att före stämman utöva sin rösträtt per post. Någon servering kommer inte att förekomma. Demonstration och visning av bolagets produkter som normalt görs i samband med stämman är inställd. Frågor till bolagsledningen kan skickas till info@msab.com . Mot bakgrund av myndigheternas föreskrifter uppmanas alla aktieägare att överväga att istället för att närvara fysiskt vid stämman utnyttja...

Continue reading

Pactiv Evergreen Inc. Schedules First Quarter 2021 Financial Results

LAKE FOREST, Ill., April 09, 2021 (GLOBE NEWSWIRE) — Pactiv Evergreen (NASDAQ: PTVE) today announced the following details for its first quarter 2021 earnings release and teleconference call.             Earnings release:  Wednesday, May 5, 2021 after market close   Webcast and Teleconference: Thursday, May 6, 2021 at 8:30 a.m. ET.   Pactiv Evergreen Participants:  Michael King, CEO  Michael Ragen, CFO/COO  Dhaval Patel, SVP, IR & StrategyParticipants may access the live webcast on the Company’s Investor Relations website at https://investors.pactivevergreen.com/ under “News & Events.” The call may also be accessed by dialing (855) 327-6837 from the U.S. or (631) 891-4304 internationally and using access code 10014019. About Pactiv Evergreen Inc. (NASDAQ: PTVE)Pactiv Evergreen Inc. is a manufacturer...

Continue reading

Fox River Closes Oversubscribed Private Placement Financing

TORONTO, April 09, 2021 (GLOBE NEWSWIRE) — Fox River Resources Corporation (the “Company”) (CSE: FOX) is pleased to announce that it has closed the non-brokered private placement (the “Offering”) announced on March 24, 2021, which was subsequently increased to $2,200,000 on March 29, 2021. Pursuant to the Offering, the Company issued 8,800,000 common shares at $0.25 per common share for aggregate gross proceeds of $2,200,000. The gross proceeds of the Offering will be used for the exploration and advancement of the Company’s Martison Phosphate Project, and for general corporate purposes. Each of the securities issued under the Offering are subject to a hold period under Canadian law which will expire four months and one day from the closing date of the Offering, being August 10, 2021. The Company paid finders fees in compliance...

Continue reading

Convocation annual general meeting and extraordinary general shareholders meeting

Regulated informationNazareth (Belgium)/Rotterdam (Netherlands), 9 April 2021 Convocation annual general meeting and extraordinary general shareholders meeting The board of directors of Fagron NV (the Company) has the honour of inviting the holders of securities and subscription rights to attend (i) the annual general shareholders meeting of the Company which will be held at the statutory seat of the Company to which the shareholders are requested to participate via audio/video conference, on Monday 10 May 2021 at 3 p.m. CET (Belgian time) and, following immediately thereafter (ii) the extraordinary general shareholders meeting in the presence of associated civil-law notary Stijn Raes. The convening notice, agenda and other documents relating to the shareholders meeting and the extraordinary general shareholders meeting can be consulted...

Continue reading

Oproeping jaarvergadering en buitengewone algemene vergadering

Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 9 april 2021 Oproeping jaarvergadering en buitengewone algemene vergadering De raad van bestuur van Fagron NV (de Vennootschap) heeft de eer de houders van aandelen en inschrijvingsrechten uit te nodigen tot het bijwonen van (i) de jaarvergadering die zal gehouden worden op de zetel van de Vennootschap waartoe de aandeelhouders worden verzocht deel te nemen via audio/video conferentie op maandag 10 mei 2021 om 15.00 uur en, onmiddellijk aansluitend hierop (ii) de buitengewone algemene vergadering die zal worden gehouden ten overstaan van notaris Stijn Raes. De oproeping, agenda en andere documenten met betrekking tot de jaarvergadering en de buitengewone algemene vergadering kunnen geraadpleegd worden op de website van de Vennootschap. Voor meer informatieConstantijn...

Continue reading

Manitou Gold Announces Closing of $5,031,000 Private Placement, Strategic Investments by Alamos Gold and O3 Mining

SUDBURY, Ontario, April 09, 2021 (GLOBE NEWSWIRE) — Manitou Gold Inc. (TSXV: MTU) (the “Company” or “Manitou”) is pleased to announce that it has closed its previously announced private placement (the “Offering”) pursuant to which it has issued an aggregate of 45,740,909 “flow-through” common shares (“FT Shares”) at a price of $0.11 per FT Share to raise aggregate gross proceeds of $5,031,500. The Company also issued an aggregate of 1,381,864 broker warrants to certain eligible registrants assisting in the Offering, each entitling the holder to acquire one common share of the Company at a purchase price of $0.11 per share for a period of three years from the closing of the Offering. An amount equal to the gross proceeds from the sale of the FT Shares will be used for expenditures which qualify as Canadian exploration expenses (“CEE”)...

Continue reading

Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion

PALO ALTO, Calif., April 09, 2021 (GLOBE NEWSWIRE) — Scilex Holding (“Scilex”), an over 99% owned subsidiary of Sorrento Therapeutics (NASDAQ: SRNE, “Sorrento”), has received a supplemental new drug application (sNDA) approval from the FDA for ZTlido® to make efficacy labeling change with clinical data. ZTlido® is the only lidocaine topical system that has been studied under the water stress conditions, and now has FDA label reflecting its use while showering, swimming and bathing. It gives polymer-based ZTlido® a competitive edge as other systems, especially water-based or hydrogel-based formulations, cannot be used when wet and must be removed prior to water exposure. In the previous clinical trial (NCT04784728), a randomized, crossover, adhesion performance and pharmacokinetic study under conditions of water exposure in healthy...

Continue reading

Copperstone completes a directed issue of shares and receiving proceeds of SEK 96 million

This press release may not be made public, published or distributed, directly and indirectly, within or to the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or any other jurisdiction where such action would be unlawful or subject to legal restrictions. Press releaseKiruna 9 April 2021 The board of directors of Copperstone Resources AB (publ) (“Copperstone” or “the Company”) resolved on a directed issue of up to 128,255,140 shares (the “Directed Issue”) on 9 April 2021 to a subscription price of SEK 0.75 per share. Through the Directed Issue, the Company receives proceeds of approximately SEK 96 million before transaction costs of approximately SEK 1.5 million. RoosGruppen AB has subscribed for SEK 25 million in the Directed Issue. The board of directors of Copperstone has, based...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.